Form 8-K - Current report:
SEC Accession No. 0001193125-23-259075
Filing Date
2023-10-19
Accepted
2023-10-19 11:14:59
Documents
12
Period of Report
2023-10-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d549040d8k.htm   iXBRL 8-K 24970
  Complete submission text file 0001193125-23-259075.txt   143604

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sgen-20231019.xsd EX-101.SCH 2875
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgen-20231019_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgen-20231019_pre.xml EX-101.PRE 10829
6 EXTRACTED XBRL INSTANCE DOCUMENT d549040d8k_htm.xml XML 3203
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Filer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32405 | Film No.: 231333870
SIC: 2836 Biological Products, (No Diagnostic Substances)